Clinical tumour markers in lung cancer

J Niklinski, M Furman - European Journal of Cancer Prevention, 1995 - journals.lww.com
… of stagc and prognosis in Nmall cell lung cancer, a multivarıatc analysis. C'un er 66: 722
M2 Gropp C, Havemann K, Lehmann HG (1978) C'arcinocmbryonic antıgen and ferritin ın …

Tumor markers in detection of lung cancer

J Schneider - Advances in clinical chemistry, 2006 - Elsevier
… and biological behavior of lung tumors. This chapter presents data on lung cancer detection,
involving some … Multivariate survival analysis for patients with NSCLC demonstrated that the …

[HTML][HTML] Genetic markers in lung cancer diagnosis: a review

K Wadowska, I Bil-Lula, Ł Trembecki… - International journal of …, 2020 - mdpi.com
Lung cancer is the result of multistage carcinogenesis with … genetic markers could enable
the diagnosis of lung cancer at its early … The analysis of the lung cancer genome is focused on …

Prognostic molecular markers in non-small cell lung cancer

J Nikliński, W Niklińska, J Laudanski, E Chyczewska… - Lung cancer, 2001 - Elsevier
markers especially in the early stage of NSCLC. Most of these investigations, however,
analysed … In our recently published study we have analysed p53 abnormalities both by direct …

Do molecular markers predict survival in non–small-cell lung cancer?

TM Greatens, GA Niehans, JB Rubins… - American journal of …, 1998 - atsjournals.org
analyses we reclassified each immunostain as being lightly stained or heavily stained,
choosing cutoff values to provide roughly equal numbers in each category for all markers. After …

[HTML][HTML] A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers

TA D'Amico, M Massey, JE Herndon II… - The Journal of thoracic …, 1999 - Elsevier
… This study evaluates a panel of molecular markers in a large population of patients with
stage I non–small cell lung cancer to determine the prognostic value of each marker and to …

Biological marker analysis as part of the CIBERES-RTIC Cancer-SEPAR strategic project on lung cancer

E Monsó, LM Montuenga, JS de Cos… - Archivos de …, 2015 - Elsevier
… /IIp cancer patients that have undergone surgery. The first cohort, the retrospective International
Association for the Study of Lung Cancer (… by SEPAR's Lung Cancer Cooperative Group (…

Evaluation of different markers in non-small cell lung cancer: prognostic value of clinical staging, tumour cell detection and tumour marker analysis for tumour …

S Kasimir-Bauer, N Schleucher… - Oncology …, 2003 - spandidos-publications.com
… value of the diverse markers used in the diagnosis of NSCLC, including routine pathology…
marker analysis with regard to TTP and OS. Taking together our results for all analysed markers

Meta-analysis of circulating tumor cells as a prognostic marker in lung cancer

XL Ma, ZL Xiao, L Liu, XX Liu, W Nie, P Li… - … journal of cancer …, 2012 - journal.waocp.org
… In conclusion, the meta-analysis suggested that the both pro- and post-treatment CTCs
appearance in peripheral blood were associated with poor prognosis in lung cancer patients. It …

[HTML][HTML] Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and-independent approaches

MG Krebs, JM Hou, R Sloane, L Lancashire… - Journal of thoracic …, 2012 - Elsevier
… In a previous study of breast cancer patients, single CTCs were negative for Ki67. The …
breast cancer CTCs and lung cancer CTCs is consistent with disseminated breast cancer cells …